임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

1상모집 예정· Healthy Subjects
Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
리드: 유한양행
상세 →NCT07584304
3상모집 예정· Hypertension
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
리드: 한미약품
상세 →NCT07660796
1상모집 중· Healthy Subjects
Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
리드: 유한양행
상세 →NCT07470125
해당없음모집 예정· Chronic Coronary Syndrome
Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome
협력: 종근당
상세 →NCT07577518
2상모집 중· Primary Brain Tumor
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
상세 →NCT07688356
3상모집 예정· Varicella (Chickenpox)
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
리드: SK바이오사이언스
상세 →NCT07415252
3상모집 예정· T2DM (Type 2 Diabetes Mellitus)
To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
상세 →NCT07619833
1상모집 예정· Ovarian Cancer
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
리드: 종근당
상세 →NCT07532148
2상모집 중· Type 2 Diabetes Mellitus
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
상세 →NCT07527650
1상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM)
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
리드: 셀트리온
상세 →NCT07533539
1상모집 중· Obesity & Overweight
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT07539415
단계 미표기모집 예정· Dyslipidemia
Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study
리드: 대웅제약
상세 →NCT07515560
단계 미표기모집 예정· Peptic Ulcer
Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
리드: 대웅제약
상세 →NCT07558707
1상모집 중· Cancer
Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
리드: 대웅제약
상세 →NCT07371104
해당없음모집 예정· Respiratory Infection Virus
Noseguard for Prevention of Respiratory Infections in Real-World Use
리드: 대웅제약
상세 →NCT07516977
1/2상모집 중· Advanced Solid Tumors
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
리드: 종근당
상세 →NCT07439094
3상모집 중· Type 2 Diabetes
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
리드: 한미약품
상세 →NCT07379333
1상모집 중· Healthy
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
리드: JW중외제약
상세 →NCT07514780
4상모집 예정· NSAID (Non-Steroidal Anti-Inflammatory Drug)
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
상세 →NCT07533266
2상완료· Age-Related Macular Degeneration
A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV
리드: 삼성바이오에피스
상세 →NCT07550504
2상모집 중· Allergic Diseases
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
리드: 유한양행
상세 →NCT07415551
1상모집 중· Advanced Solid Tumors
A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
리드: 삼성바이오에피스
상세 →NCT07524348
3상모집 중· Varicella (Chickenpox)
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
리드: GC녹십자
상세 →NCT07054099
해당없음모집 중· Dyslipidemia Associated With Type II Diabetes Mellitus
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
협력: 한미약품, 유한양행
상세 →NCT07359105
4상모집 예정· Diabete Type 2
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
리드: 종근당
상세 →NCT07365358
1상모집 예정· Benign Prostate Hypertrophy(BPH)
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
리드: 종근당
상세 →NCT07404735
3상모집 중· Stomach (Gastric) Cancer
PROGAIN Trial in Gastric Cancer Surgery
협력: JW중외제약
상세 →NCT07488611
2상모집 중· Advanced or Metastatic Melanoma
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
상세 →NCT07449754
1상모집 중· Atopic Dermatitis
A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
리드: 종근당
상세 →NCT07358156
3상모집 중· Menorrhagia
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
리드: JW중외제약
상세 →NCT07378098
1상완료· Healthy
To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
리드: JW중외제약
상세 →NCT07374406
1/2상모집 중· Healthy Participants
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
리드: SK바이오사이언스
상세 →NCT07280858
1상완료· Healthy Male Subjects
A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
리드: 셀트리온
상세 →NCT07367958
1상모집 예정· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers
리드: 한미약품
상세 →NCT07297693
2상모집 중단 (진행 중)· Obese
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
상세 →NCT07205900
1상모집 중· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
리드: 대웅제약
상세 →NCT07267221
1상모집 중· Psoriasis
Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
리드: 종근당
상세 →NCT07258745
단계 미표기모집 중· Ulcerative Colitis (UC)
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
협력: 셀트리온
상세 →NCT07237516
1상완료· Healthy Subjects
PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
리드: 대웅제약
상세 →NCT07256600
1상완료· Healthy
Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
리드: 대웅제약
상세 →NCT07213310
1상모집 중· Obesity
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
리드: 한미약품
상세 →NCT07219589
1상모집 중· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
리드: 대웅제약
상세 →NCT07260851
1상완료· Type 2 Diabetes
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
리드: 종근당
상세 →NCT07304726
4상모집 중· Type 2 Diabetes Mellitus (T2DM)
Glycemic Variability of Combination Therapies in T2DM
리드: JW중외제약
상세 →NCT07442006
1상완료· Type 2 Diabetes
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers
리드: 종근당
상세 →NCT07304700
1상완료· Type 2 Diabetes
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
리드: 종근당
상세 →NCT07304687
해당없음모집 중· Hypertension
CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
협력: 대웅제약
상세 →NCT07465549
1상완료· Healthy Subjects
Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects
리드: 유한양행
상세 →NCT07265167
1상모집 중· Advanced Solid Tumors
Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
리드: 종근당
상세 →NCT07215637
단계 미표기모집 중· Chronic Spontaneous Urticaria (CSU)
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
리드: 셀트리온
상세 →NCT07425639
단계 미표기모집 예정· Psoriasis
Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
리드: 대웅제약
상세 →NCT07190391
1상모집 중단 (진행 중)· Healthy Participants
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
리드: 셀트리온
상세 →NCT07200986
1상완료· Healthy
A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers
리드: 셀트리온
상세 →NCT07128654
단계 미표기모집 중· Stage 1 Hypertension
Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
리드: 대웅제약
상세 →NCT07515599
1상모집 중· Healthy Subjects
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
리드: 대웅제약
상세 →NCT07144176
1상완료· Healthy Male Adults
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
리드: JW중외제약
상세 →NCT07036458
3상완료· Acute Bronchitis
Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
리드: 유한양행
상세 →NCT07111468
1상완료· Type 2 Diabetes Mellitus (T2DM)
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
리드: 셀트리온
상세 →NCT07158346
4상모집 예정· Heart Transplant
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
리드: 종근당
상세 →NCT06942156
3상모집 중· Refractory or Relapsed Multiple Myeloma
A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
리드: 셀트리온
상세 →NCT06952478

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.